DERM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DERM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Journey Medical's average Accounts Payable for the three months ended in Dec. 2024 was $15.69 Mil. Journey Medical's Cost of Goods Sold for the three months ended in Dec. 2024 was $2.24 Mil. Hence, Journey Medical's Days Payable for the three months ended in Dec. 2024 was 640.20.
The historical rank and industry rank for Journey Medical's Days Payable or its related term are showing as below:
During the past 6 years, Journey Medical's highest Days Payable was 439.51. The lowest was 50.82. And the median was 221.73.
Journey Medical's Days Payable declined from Dec. 2023 (962.14) to Dec. 2024 (640.20). It may suggest that Journey Medical accelerated paying its suppliers.
The historical data trend for Journey Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Journey Medical Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Days Payable | Get a 7-Day Free Trial | 50.82 | 144.53 | 358.39 | 439.51 | 298.93 |
Journey Medical Quarterly Data | ||||||||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Days Payable | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
962.14 | 225.51 | 210.27 | 258.50 | 640.20 |
For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Journey Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Journey Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Journey Medical's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
Days Payable (A: Dec. 2024 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Dec. 2023 ) | + | Accounts Payable (A: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2024 ) | * | Days in Period |
= | ( (18.149 | + | 16.05) | / | 2 ) | / | 20.879 | * | 365 |
= | 17.0995 | / | 20.879 | * | 365 | ||||
= | 298.93 |
Journey Medical's Days Payable for the quarter that ended in Dec. 2024 is calculated as:
Days Payable (Q: Dec. 2024 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: Sep. 2024 ) | + | Accounts Payable (Q: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2024 ) | * | Days in Period |
= | ( (15.339 | + | 16.05) | / | 2 ) | / | 2.237 | * | 365 / 4 |
= | 15.6945 | / | 2.237 | * | 365 / 4 | ||||
= | 640.20 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Journey Medical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Claude Maraoui | director, officer: President & CEO | C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE AZ 85258 |
Joseph Benesch | officer: Interim CFO | C/O TELIGENT, 105 LINCOLN AVENUE, BUENA NJ 08310 |
Rosenwald Lindsay A Md | director | 375 PARK AVE, NEW YORK NY 10152 |
Justin Adam Smith | director | C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE AZ 85258 |
Jeffrey Paley | director | C/O RETROPHIN INC., 777 THIRD AVENUE, 22ND FLOOR, NEW YORK NY 10017 |
De Paolantonio Ernest Robert | officer: Chief Financial Officer | 4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC 27612 |
Neil Herskowitz | director | 2109 BROADWAY, SUITE 206, NEW YORK NY 10023 |
Miranda Jayne Toledano | director | C/O COMPASS THERAPEUTICS, INC., 80 GUEST STREET, SUITE 601, BOSTON MA 02135 |
From GuruFocus
By GuruFocus Research • 05-14-2024
By Marketwired • 08-12-2024
By GuruFocus Research • 02-06-2024
By GuruFocus News • 11-12-2024
By GuruFocus Research • 03-25-2024
By Marketwired • 03-12-2025
By GuruFocus Research • 02-06-2024
By Marketwired • 01-23-2025
By Marketwired • 11-12-2024
By Marketwired • 09-04-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.